Location: Palo Alto, CA
CIK: 0001664974 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $78.55M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 4,590,000 | $26.62M | 33.9% | — | — | COM CL A | 30049H102 |
| HQ | Horizon Quantum Holdings Ltd | 915,198 | $25.41M | 32.3% | — | — | CL A ORD SHS | Y4000A102 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $21.8M | 27.8% | — | — | CL A | 75629V104 |
| DFTX | Definium Therapeutics, Inc. (MindMed) | 100,350 | $4.72M | 6.0% | — | — | COM SHS | 24477V105 |